Tar Heel Times
Your comprehensive source for Tar Heel sports news

UNC ranked 7th among biomedical research institutions


Researchers at the University of North Carolina at Chapel Hill are using genetically engineered mouse models to help predict how humans will respond to different chemotherapy drug combinations used to fight breast cancer. Last year, UNC scientists identified biomarkers for challenging molecular subtypes of human breast cancer in genetically engineered mice, specifically looking for types that have few known targets and available therapies. (Fierce Biotech Research)


Share: Facebook | Twitter | Email

Related:

Recent Campus Connections News:

UNC-Chapel Hill named to President’s Honor Roll for Public Service

The movie inspired by a UNC professor's book is premiering today

New leads pour in on Faith Hedgepeth murder after television special

From Chapel Hill to Africa, Tim Crothers Writes to Inspire

UNC ranks 3rd among public universities in new measure of graduate success, student learning


© 2005-2016 Tar Heel Times | Contact | Privacy Policy | Site Map | RSS | Did UNC Win?

Tar Heel Times is an unofficial resource for UNC fans and is not affiliated with the University of North Carolina.